Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Brain and Central Nervous System TumorsLymphoma
Interventions
DRUG

rituximab

375 mg/m2, intravenously three days prior to the first cycle of methotrexate

DRUG

methotrexate

Five cycles of methotrexate (MTX) at 3.5 gm/m2 administered every two weeks on weeks 1, 3, 5, 7, and 9 via intravenous infusion over four hours once per cycle. Calcium leucovorin 25 mg orally or intravenously every six hours initiated exactly 24 hours following the start of the MTX infusion. Methotrexate levels to be monitored daily, and calcium leucovorin discontinued when the MTX level is less than 10 micromolar.

DRUG

temozolomide 100 mg/m^2

Temozolomide 100 mg/m\^2 by mouth per day for five days on weeks 4 and 8.

DRUG

temozolomide 150 mg/m^2

Temozolomide 150 mg/m\^2 by mouth per day for five days on weeks 4 and 8.

DRUG

temozolomide 200 mg/m^2

Temozolomide 200 mg/m\^2 per day by mouth for five days on weeks 4 and 8.

RADIATION

radiation therapy

Whole brain irradiation (WBRT) during weeks 11, 12, and 13, five days per week (excluding weekends). A daily dose of 2.4 Gy delivered in two fractions of 1.2 Gy each with a minimum inter-fraction interval of 6 hours, with a total dose to brain and meninges of 36 Gy.

DRUG

post-radiation therapy temozolomide

Temozolomide (TMZ) 200 mg/m\^2 by mouth per day for 5 days on weeks 14, 18, 22, 26, 30, 34, 38, 42, 46, and 50 for a total of 10 cycles.

Trial Locations (26)

29425

Hollings Cancer Center at Medical University of South Carolina, Charleston

32073

Integrated Community Oncology Network - Orange Park, Orange Park

32086

Flagler Cancer Center, Saint Augustine

32177

Florida Cancer Center - Palatka, Palatka

32207

Baptist Cancer Institute - Jacksonville, Jacksonville

Integrated Community Oncology Network at Southside Cancer Center, Jacksonville

32250

Integrated Community Oncology Network, Jacksonville Beach

32258

Baptist Medical Center South, Jacksonville

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

49001

Borgess Medical Center, Kalamazoo

49007

Bronson Methodist Hospital, Kalamazoo

53051

Community Memorial Hospital Cancer Care Center, Menomonee Falls

53226

Medical College of Wisconsin Cancer Center, Milwaukee

63110

Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, St Louis

64131

CCOP - Kansas City, Kansas City

84157

Jon and Karen Huntsman Cancer Center at Intermountain Medical Center, Murray

84604

Utah Valley Regional Medical Center - Provo, Provo

89106

CCOP - Nevada Cancer Research Foundation, Las Vegas

97222

Providence Milwaukie Hospital, Milwaukie

97225

CCOP - Columbia River Oncology Program, Portland

Providence St. Vincent Medical Center, Portland

98668

Southwest Washington Medical Center Cancer Center, Vancouver

49007-3731

West Michigan Cancer Center, Kalamazoo

08818

John F. Kennedy Medical Center, Edison

97213-2967

Providence Cancer Center at Providence Portland Medical Center, Portland

19107-5541

Kimmel Cancer Center at Thomas Jefferson University - Philadelphia, Philadelphia

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

NRG Oncology

OTHER

lead

Radiation Therapy Oncology Group

NETWORK